Epidemiological data showed that a significant increase in the risk of severe side-effects could appear at levels as low as 0.5 g/year and became highly significant at levels >1 g/year [ 37 , 43 ].
← all excerpts
Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity.
1
—
—